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This article takes four looks at the status of prevention in psychiatry. The first glance is
critical, shaped by disappointment at the slow progress in the understanding of psychiatric
diseases and the lack of promise in prevention. The second look is less humble. It charac-
terizes and acknowledges the efforts made so far. The third and the fourth perspectives
optimistically announce a new age in research and prevention. Breakthroughs, whose con-
tours are already appearing on the horizon today, will transform the prevention of psychiatric
diseases into a success story within the next 10–15 years.
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A CRITICAL FIRST GLANCE
There are a great many arguments that can lead us to doubt the
prospects of psychiatric research and therapy:
• the conflicting discussions on the number of diagnoses imple-
mented in the new version of the Diagnostic and Statistical Man-
ual of Mental Disorders (1): overtly anachronistic if psychiatry
were a developing discipline;
• the continuing failure to understand the etiopathogenesis of psy-
chiatric diseases – the terms psychiatric diseases and mental
disorders are used interchangeably – despite progressing basic
research in neurosciences and the availability of myriads of
empirical results;
• the difficulties in supplementing categorical with dimensional
concepts in disease models and thinking about psychiatric
diagnoses (2);
• the lack of major discoveries and innovations in research,
therapies, and drug development in recent decades (3);
• the missionary impetus of new and highly redundant concepts
related to positive mental health such as locus of control, self-
efficacy, hardiness, sense of coherence, emotional intelligence,
resilience, coping etc.
In prevention, the disastrous state of affairs is primarily mir-
rored by the lack of primary – in particular, universal – prevention
efforts. Disappointment is apparent in the 2001 WHO report
(4), which stated (p. 64): “Currently, there is no evidence that
interventions proposed for primary prevention of depression are
effective except in a few isolated studies. Currently, primary pre-
vention of schizophrenia is not possible. The precise etiology
of the hyperkinetic disorders – hyperactivity in children, often
with involuntary muscular spasms – is unknown, thus primary
prevention is currently not possible.”
In the meantime, further WHO reports (5–7) and reports
from other organizations have been published. Many setting- and
group-specific prevention projects have been initiated. However,
there is still no sufficient knowledge about specific risk factors and
specific etiopathogenic mechanisms that could be implemented in
specific prevention measures. Most of the known biopsychosocial
risk factors are generic and apply to many neuropsychiatric and
psychiatric diseases (Table 1).
While some of the risk factors (physical and sexual abuse, bul-
lying, maternal infections during pregnancy) would be effectively
approachable via primary prevention measures, this is difficult for
other risk factors (unemployment, loss of loved ones, etc.), where
prevention can hardly overcome the limitation of being a drop in
the bucket. Behavioral changes in the population, either culturally
or socioeconomically shaped, easily overshadow any well-intended
efforts.
Nevertheless, given the profile of most psychiatric diseases –
young age at onset, chronic course, high levels of comorbidity –
effective primary prevention measures would be extraordinarily
beneficial. Meanwhile, there is no intentional, thoughtful univer-
sal prevention addressing large groups of the population or the
population as a whole.
To make matters worse, public mental health (and thereby
implicitly the prevention of psychiatric diseases) is subject to
norms, hopes, and targets developed in public health, which in
their turn have emerged from highly developed and successful sub-
disciplines dealing with infectious diseases, cardiovascular diseases
(CVDs), or cancer. What would public health look like if it cared
about the most difficult issues, for example autoimmune or neu-
rological diseases, i.e., complex diseases with a largely unknown
etiology, pure therapeutic opportunities, early age at onset, and
a typically chronic course? This rhetorical question makes clear
that the perception of what public health is and what preven-
tion should do, is highly skewed. Focusing on diseases of old age
and a couple of acute diseases is not the main scope of public
mental health or of public health related to autoimmunity and
neurology.
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Table 1 | Risk factors for mental disorders.
Pregnancy/delivery
Infectious diseases
Substance abuse
Famine/poor diet
Complications during pregnancy
Complications during delivery
Preterm delivery, low/high birth weight
Violence, deprivation during childhood
Abuse, violence (emotional, physical)
Neglect (emotional, physical)
Quarrels between parents, close others
Other adversities in childhood
Broken home
Substance abuse of parents
Quarrels with other children, bullying
Problems with teacher, fear of school
Other violence
Violence, bullying in family
Violence to close others
Bullying in childhood, adolescence, adulthood, at work
Sexual abuse
Being the victim of violence in a public space
Substance abuse in adolescence, adulthood
Cannabis
Smoking
Alcohol
Illicit drugs
Poly-drug use
Traumatic events
Serious somatic illness, stroke
War, natural disaster, etc.
Accidents
Loss of loved ones (e.g., through suicide, bereavement,
separation/divorce)
Chronic distress
Chronic pain
No control over stressors
Burnout/boreout
Care of demented family members, geriatric, or long-term care
Hormonally driven symptoms
Menstruation-related symptoms
Postpartum symptoms
Infectious diseases
Symptoms related to postinfectious fatigue or depression
Infectious diseases during pregnancy/childhood/adulthood
Not unequivocally referable or reciprocal risk factors
Poor diet
Sleep problems
Urbanicity
Migration
A SECOND GLANCE: PROMISING EFFORTS
However, things are too complex to be desperate. Basically, we need
to distinguish four fields of interest (Figure 1). Apart from somatic
and mental health, behavioral disorders and positive health are also
included. Notably, the relations of these components are at least
as specific as the components themselves.
The model shows at a glance that prevention of mental disor-
ders involves not only diagnoses and symptoms but at least also
behaviors such as suicide, substance use, and others that are related
to somatic functions (sleep,eating, etc.). There are basic differences
between the prevention of mental disorders and the prevention of
behavioral disorders. Typically, the latter offer more opportunities
than the former, and promise to be more successful. Suicide is an
interesting example for several reasons.
A recent noteworthy aspect of suicide is the unexpected 20–
40% decrease in rates in many Western countries over recent
decades. This not only offers challenging opportunities to learn
about underlying mechanisms but also indicates that behavioral
disorders are rarely static, often undergo change, and thus make
prevention efforts promising.
Furthermore, suicide can serve as a model for the utility of
differentiating prevention domains in behavioral disorders:
• methods/means of suicide
• imitation suicides (media, other sources of information, school
classes)
• risk groups, persons at increased risk
• professionals
• information/education (mental health literacy, knowledge about
institutions and professionals providing help, problem-solving
competence, etc.)
• easily accessible support facilities, helplines (for both persons
with increased risk and professionals)
• available inpatient and outpatient mental health services
• developed emergency medicine.
In terms of these domains, the recent decrease in suicide rates
has been attributed to increasing prescription rates of antide-
pressants, that is, to improved services (8). While some authors
attribute this development to the availability of selective serotonin
reuptake inhibitors (SSRIs), it seems no less realistic in the era of
stress and burnout that the help-seeking behavior of young and
better educated persons has distinctly changed – and thus also the
demand for services.
The spectrum of relevant prevention domains may diverge
among distinct behavioral disorders. However, approaching
means and behaviors always remains an additional option apart
from addressing emotions and mood. Most importantly, preven-
tion measures here also include primary and universal prevention.
The measures can be both indirect and direct, i.e., address the
target behavior specifically. The case of suicide shows that preven-
tion has more levers in some areas of public mental health than in
others.
The second glance at current prevention measures also reveals
a complex picture regarding mental disorders and additionally
dampens the initial disappointment. First of all, there are many
measures that cover primary prevention but are indirect. This
means that they target a particular issue and en passant involve –
intended or unintended – beneficial effects for mental health
as well:
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FIGURE 1 | Components of a general model of health / public health.
• violence prevention
• injury prevention
• prevention of other traumatic events
• prenatal health, coaching, and care of pregnant mothers
• prevention of substance use and infectious diseases (rubella,
Toxoplasma gondii) during pregnancy
• counseling in families at risk
• coaching of adolescent mothers
• prevention of infectious diseases known to increase the risk for
psychiatric diseases
• substance abuse and addictive behavior prevention
• voluntary community work, social support, neighborhood net-
works
• projects and measures addressing health promotion, health
literacy, healthy behaviors
Currently available direct prevention measures or projects are
often related to specific settings, for example, school, university,
military, work settings, health services (9). Again, there are univer-
sal, selective, and indicated approaches, particularly heterogeneous
in the school setting (10) and, besides, shown to reduce for exam-
ple the depression incidence by 25% (11). The effect sizes can
be expected to be different between the prevention approaches,
i.e., higher in selective and indicated prevention, however, the
outcomes are not unambiguous (12). A major problem in school-
based universal prevention programs is that the effects appear to
evaporate in the medium and long run.
How broad the spectrum of prevention approaches (univer-
sal, selective, indicated) is not only dependent on the settings
but also on the disorders targeted. The earlier a disorder starts
and the more frequent it is, the more pressure increases to
begin prevention early in life and to use all accessible tools. This
applies not only to anxiety disorders (13), but also to mood
disorders (14). In contrast, efforts in the prevention of bor-
derline personality disorder (15), psychosis, and schizophrenia
(16, 17) are mostly limited to selective prevention (addressing
persons at risk) or to indicated prevention (addressing per-
sons with symptoms or subthreshold diagnoses) even though
the potential for universal prevention should not be underesti-
mated (18, 19).
A second large group of prevention measures is integrated in
regional or national campaigns located at the borderline between
primary and secondary prevention (20). One major direction is
to fight stigma of mental disorders [see, for example the “time
to change” campaign (21)], not only to improve the social sta-
tus of mentally ill persons but also to encourage people to seek
help early when encountering mental problems. Another major
direction is to improve knowledge (mental health literacy) and to
change attitudes toward mental health and mental illness in gen-
eral. An example of such a campaign is the Nuremberg alliance
against depression (22), which follows several aims at once within
a concerted action plan: training and support of family doctors,
public relations campaigns providing information about depres-
sion, cooperation with professionals and local media, and support
for self-help activities and for high-risk groups.
The Nuremberg campaign is particularly intriguing because
it shows that population-related prevention programs can be
successful and that their success depends mainly on two
components:
• the coordinated implementation of several synergistic actions
addressing different groups (in this instance lay persons, affected
persons, physicians, professionals);
• the need for continuing actions at lower levels after a major
program in order to ascertain sustainable effects.
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A THIRD GLANCE: EMERGING PARALLELS TO PREVENTION
OF CARDIOVASCULAR AND INFECTIOUS DISEASES
The disappointment at prevention in the past and the cautious
curiosity about many new trends in current prevention contrast
with their prospects in the future. There are many reasons for
optimism. The first is a simple backlog effect: given that psychi-
atry – including prevention and other domains of public mental
health – distinctly lags behind most domains of somatic medi-
cine, it follows that much remains to be developed and to be done.
The burning question, however, is when the next transition in
psychiatry will start.
More and more signs are emerging that the next move is draw-
ing closer. Among these signs are the increasingly recognized
comorbidities and other parallels with somatic diseases, the next
component of the four-field health scheme (see Figure 1). The
manifold associations between psychiatric and allergic diseases are
perhaps the most striking links (23, 24), while the links to CVDs
are certainly the best-known ones (25).
Apart from comorbidity measures, common risk factors such
as obesity and poor diet, smoking, and physical inactivity also
strengthen the link between CVD and common mental disor-
ders (CMD) such as depression [for an overview see Ref. (26)].
The most probable common denominator is systemic inflam-
mation and immune dysregulation (27). Jacka and Berk have
emphasized the idea that most of the prevention done within
the context of CVD encompasses in principle also common in
mental disorders such as depression. Thus, prevention related to
life-style factors emerges as a new pathway, not only in CMD
but also in schizophrenia (28) and, possibly, other mental dis-
orders as well. For example, the intake of omega-3 fatty acids
is a current subject of trials (29). A particularly interesting
side-effect is that life-style factors open the gate to universal
prevention.
Another challenging pathway for universal prevention emerges
from the associations between psychiatric and autoimmune dis-
eases (30–32). There is even growing evidence that some psy-
chiatric diseases – for example, some subtypes of OCD and
ADHD – are autoimmune diseases in the narrow sense (33).
Autoimmunity is typically related to an infectious disease eti-
ology. As a matter of coincidence, it is foreseeable from upcoming
research that infectious diseases are important risk factors in men-
tal disorders (34, 35). Thus, many risk factors and markers grad-
ually emerge in a different light: the social class gradient, familial
aggregation, sex-ratios, etc. Equally, many opportunities for pre-
vention are appearing on the horizon which are similar to those
in somatic medicine – and no less promising: hygiene, vaccines,
appropriate treatment of noxious microbes, etc.
A FOURTH GLANCE: PREVENTION IN PSYCHIATRY WILL
WORK BETTER THAN PREVENTION IN SOMATIC MEDICINE
While prevention of psychiatric diseases will presumably grow
closer to prevention in somatic medicine, it will nonetheless retain
genuine advantages. First, given that psychiatric diseases typically
emerge from two or even more “hits” (36), there must also be
several opportunities for prevention to intervene and modify the
risk of definitively developing a psychiatric disease or more serious
symptoms.
Second, the etiopathogenesis of psychiatric diseases obviously
involves age stages of enhanced vulnerability. It is deducible from
the age at onset parameters that the “multiple hits” occur not only
in different combinations but also during different age stages. Bet-
ter knowledge of biologically and psycho-socially vulnerable age
stages and the risk mechanisms involved will help to focus and
optimize preventive efforts.
Third, the notion that the autoimmunity link applies for some
subtypes of ADHD or OCD directs attention to the subtyping
of existing psychiatric diagnoses. It is foreseeable that progress in
research and advances in subtyping will lead not only to thicker
diagnostic manuals but also to more specific information about
specific disease characteristics, brain networks involved, risk fac-
tors, etiopathogenic concepts,vulnerable age stages. Subtyping will
finally lead to prevention strategies that may be better tailored to
specific diseases and risk groups.
There are even more promising prospects. A particular char-
acteristic of psychiatric diseases is that they are biologically and
psycho-socially driven. Complementarily,many therapies are most
promising if they combine drugs, behavioral modification, and
psychotherapy. Strikingly, all these avenues of action are also open
for prevention, and will finally include the fourth and last compo-
nent of the four-field scheme,positive mental health (see Figure 1).
Hopefully, unambiguous concepts (37) and instruments (38, 39)
with respect to positive mental health will be developed in the
near future, capable to fulfill the precondition of being more than
a reciprocal proxy of mental illness. However, this challenge is
incomparably more complicated than in somatic health.
In sum, the next transition in psychiatry has probably already
started. Psychiatry can be expected to change considerably in the
next 10–15 years, and prevention will benefit disproportionately
from its progress. It is even imaginable that prevention in psychi-
atry will have more tools and will work better than prevention in
somatic medicine.
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